$CymaBay Therapeutics (CBAY.US)$ Holding some good support a...
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400590041583-70074865-web-8f00b204e9800998.png/bigmoo)
Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months after offering of $4/share which closed on the 11/22 I believe. Expecting Phase 2a data for short term still this year with time running out for MBX-2982 drug for Type 1 diabetes. Still undergoing enrollment on their main drug Seladelpar which is used for autoimmune liver disease with great outlook.
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400609334295-70074865-web-8f00b204e9800998.png/bigmoo)
Institutional Holdings are around 60%ish+ according to Yahoo Finance/Ortex/and Finviz while Benzinga Pro reports Institutional Holdings at around 22%
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400610894423-70074865-web-8f00b204e9800998.png/bigmoo)
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400611579108-70074865-web-8f00b204e9800998.png/bigmoo)
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400611902301-70074865-web-8f00b204e9800998.png/bigmoo)
Just back 11/11 Raymond James Maintained Strong Buy and raised PT to $14 with the average analyst PT at $11 where all are at Buy+
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400612575478-70074865-web-8f00b204e9800998.png/bigmoo)
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400613518692-70074865-web-8f00b204e9800998.png/bigmoo)
And a recent SC13G reported TCG Crossover Management having a 7% stake
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400614584707-70074865-web-8f00b204e9800998.png/bigmoo)
Furthermore, according to their last earnings call, they will have sufficient funds to continue current operations into 2023 with no mentions of further dilution.
![$CymaBay Therapeutics (CBAY.US)$ Holding some good support at this area long term. Spike in volume and price on 12/17. Has enough cash for approx 34 months afte...](https://ussnsimg.moomoo.com/16400726532937-70074865-web-8f00b204e9800998.png/bigmoo)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment